IP
DGX icon

Intellectus Partners’s Quest Diagnostics DGX Stock Holding History

Intellectus Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,108
Closed -$278K – 280
2021
Q2 		$278K Sell
2,108
-709
-25% -$92.8K 0.06% 240
2021
Q1 		$362K Buy
2,817
+1
+0% +$123 0.1% 202
2020
Q4 		$336K Hold
2,816
– – 0.1% 190
2020
Q3 		$322K Hold
2,816
– – 0.12% 170
2020
Q2 		$321K Sell
2,816
-15
-0.5% -$1.59K 0.12% 168
2020
Q1 		$227K Buy
+2,831
New +$293K 0.11% 175

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Intellectus Partners's DGX Position: Q3 2021 in Review

Intellectus Partners sold out of Quest Diagnostics (DGX) in Q3 2021, closing a stake of 2,108 shares — an estimated $278K sold.

Intellectus Partners first reported a position in DGX in Q1 2020 and held it in 6 quarters. The position peaked at $362K in Q1 2021. 838 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

  • Intellectus Partners reported no remaining Quest Diagnostics position as of Q3 2021 after selling out during the quarter.
  • Intellectus Partners sold 2,108 Quest Diagnostics shares in Q3 2021, an estimated $278K.
  • Intellectus Partners first reported a position in Quest Diagnostics in Q1 2020 and held it in 6 quarters.
  • Intellectus Partners's Quest Diagnostics position peaked at $362K in Q1 2021.
  • 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on Intellectus Partners's 13F filing for Q3 2021, filed 16 Nov 2021.